Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,776 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of bi-weekly docetaxel and carboplatin with concurrent thoracic radiation therapy followed by consolidation chemotherapy with docetaxel plus carboplatin for stage III unresectable non-small cell lung cancer.
Sakai H, Yoneda S, Kobayashi K, Komagata H, Kosaihira S, Kazumoto T, Saito Y. Sakai H, et al. Among authors: saito y. Lung Cancer. 2004 Feb;43(2):195-201. doi: 10.1016/j.lungcan.2003.08.021. Lung Cancer. 2004. PMID: 14739040 Clinical Trial.
Concurrent chemoradiotherapy followed by consolidation chemotherapy with bi-weekly docetaxel and carboplatin for stage III unresectable, non-small-cell lung cancer: clinical application of a protocol used in a previous phase II study.
Saitoh J, Saito Y, Kazumoto T, Kudo S, Yoshida D, Ichikawa A, Sakai H, Kurimoto F, Kato S, Shibuya K. Saitoh J, et al. Among authors: saito y. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1791-6. doi: 10.1016/j.ijrobp.2011.03.007. Epub 2011 May 19. Int J Radiat Oncol Biol Phys. 2012. PMID: 21601375
Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma.
Hashimoto J, Kato K, Ito Y, Kojima T, Akimoto T, Daiko H, Hamamoto Y, Matsushita H, Katano S, Hara H, Tanaka Y, Saito Y, Nagashima K, Igaki H. Hashimoto J, et al. Among authors: saito y. Int J Clin Oncol. 2019 Jan;24(1):60-67. doi: 10.1007/s10147-018-1336-x. Epub 2018 Aug 14. Int J Clin Oncol. 2019. PMID: 30109544 Clinical Trial.
9,776 results